Prof. Dr. Turgay Çelikel
OncologyVerified
- 47+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Ablation & Embolization
Nanoknife
What NanoKnife (irreversible electroporation) is, how non-thermal electrical pulses destroy cancer cells while sparing critical blood vessels and nerves, what clinical evidence indicates for locally advanced prostate, pancreatic and liver tumours, approximate costs in Turkey compared with the UK, US and Germany, candidate criteria, recovery milestones, potential complications and how to choose an experienced oncology centre.
A written plan with the surgeon's name and the full price — usually within 24 hours.
- Category
- Ablation & Embolization
- Hospitals
- 2
- Verified
- 1
- Price from
- Price on request
Verified surgeons for Nanoknife
1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
NanoKnife in Turkey: what it is and how irreversible electroporation works
NanoKnife (irreversible electroporation, or IRE) is an advanced, non-thermal focal ablation technology used in interventional oncology. Instead of relying on extreme heat or freezing, the system delivers controlled, high-voltage electrical pulses between strategically placed needle electrodes directly into soft-tissue tumours. These microsecond bursts generate an intense electrical field that opens permanent nanoscale pores in the lipid bilayers of cancer cell membranes. This process disrupts cellular homeostasis and triggers apoptosis—natural, programmed cell death—rather than uncontrolled coagulative necrosis.
Because irreversible electroporation is a non-thermal mechanism, it leaves non-cellular tissue frameworks intact. Structural proteins such as collagen and elastin, which form the supportive matrix of major blood vessels, bile ducts, ureters, and delicate nerve bundles, remain preserved. This distinctive biological property allows oncology teams to ablate tumours situated adjacent to vital structures that would otherwise be considered inoperable or unsafe for thermal destruction. When considering what is NanoKnife and how it fits into comprehensive cancer care, patients can learn more about multidisciplinary oncology treatments in Turkey.
How does the NanoKnife procedure work step by step?
The procedure begins with precise anatomical planning. High-resolution contrast-enhanced CT or MRI scans are imported into 3D navigation software. The interventional oncology team maps the tumour dimensions and calculates the exact number of electrode probes required, their geometric placement, and the specific electrical field parameters needed to ensure complete ablation margins.
On the day of treatment, the patient is placed under general anaesthesia in a specialized interventional radiology suite or operating theatre. A critical element of the protocol is the administration of complete neuromuscular blockade (deep muscle paralysis), which prevents muscle contractions that would otherwise be triggered by high-voltage currents. Additionally, the pulse generator is synchronized to the patient's electrocardiogram (ECG) using a dedicated cardiac-gating device. Electrical pulses are delivered strictly during the absolute refractory period of the heart's ventricles (the ST segment) to prevent cardiac arrhythmias.
Under real-time ultrasound, CT fluoroscopy, or robotic guidance, the specialist advances between two and six thin needle electrodes through the skin or via laparoscopy into and around the lesion. The electrodes are aligned in parallel configurations spaced approximately 1.5 to 2.0 centimetres apart. Test pulses verify electrical impedance across the tissue. The system then delivers a series of microsecond high-voltage pulses (typically 70 to 100 pulses per probe pair) to achieve cell membrane permeabilisation. Once all planned cycles are complete, the probes are withdrawn and small puncture dressings applied. The procedure generally takes between two and four hours.
Does NanoKnife actually work for pancreatic, prostate and liver tumours?
Clinical evidence demonstrates that irreversible electroporation is an effective focal therapy for selected tumour types, particularly where lesions border critical vessels that preclude standard surgical resection. The technology holds regulatory clearance from the United States Food and Drug Administration (FDA) and has CE mark approval in Europe for soft-tissue ablation. The UK National Institute for Health and Care Excellence (NICE) has issued clinical guidance on irreversible electroporation for primary liver cancer, liver metastases, and locally advanced pancreatic cancer, acknowledging safety and efficacy when conducted within specialist multidisciplinary frameworks.
In locally advanced pancreatic cancer (LAPC)—where the tumour encases the celiac axis, mesenteric arteries, or portal vein—published registries indicate that IRE can achieve local margin clearance and improve progression-free intervals when combined with standard chemotherapy. However, when asking does NanoKnife work as a standalone cure, the clinical reality is that it treats local disease rather than systemic spread; it cannot eliminate circulating micrometastases. For localized prostate cancer, focal IRE selectively destroys intermediate-risk malignant foci while preserving the surrounding neurovascular bundles, resulting in high rates of urinary continence and sexual function preservation. Trustworthy oncology specialists provide an honest assessment of whether local ablation aligns with your disease stage.
NanoKnife cost in Turkey compared with the UK, US and Germany
The table below outlines approximate price ranges for NanoKnife treatment across different countries. These figures represent broad estimates rather than individual hospital quotations. Actual costs vary based on the target organ, the number of disposable electrode probes required, procedural duration, and the extent of inpatient post-operative care.
| Country | Approximate cost range |
|---|---|
| Turkey | €11,000 – €22,000 |
| United Kingdom | €18,000 – €35,000 |
| United States | €25,000 – €55,000 |
| Germany | €16,000 – €32,000 |
What drives the overall NanoKnife cost: the primary material expense stems from the single-use electrode needle probes, which must be calibrated and discarded after each session. Treating larger or complex tumours requires additional probes, which directly increases the total NanoKnife price. Packages in Turkey typically include pre-operative imaging verification, blood panels, specialist interventional fees, anaesthetic management, consumable electrode sets, cardiac synchronisation equipment, one to three nights of private hospital accommodation, nursing care, post-treatment medications, and airport transfers.
NanoKnife, radiofrequency ablation or surgical resection?
Selecting an oncological intervention depends on tumour size, anatomical location, histological grade, and proximity to critical blood vessels. Surgical resection remains the standard choice when a tumour can be excised with clear negative margins without endangering vital structures. However, many lesions are surgically inoperable because they encase major vascular pathways. In such circumstances, image-guided ablation provides a vital treatment alternative.
Thermal techniques such as radiofrequency ablation (RFA) utilize alternating electrical current to generate intense heat, producing coagulative tissue necrosis. While effective in peripheral organ tissue, thermal ablation carries two primary limitations: the "heat-sink" effect (where rapid blood flow in adjacent large vessels draws heat away, leaving residual viable cancer cells) and the risk of thermal damage to bile ducts, bowel walls, or nerves.
| Method | Mechanism | Best suited to | Typical limits |
|---|---|---|---|
| NanoKnife (IRE) | Non-thermal high-voltage electrical pulses | Tumours bordering major vessels, bile ducts, or delicate nerves | Requires general anaesthesia, deep paralysis, and cardiac gating |
| Radiofrequency ablation | Frictional heat from alternating electrical current | Small, isolated tumours in the liver or lung away from vital structures | Heat-sink effect near large blood vessels; risk of thermal damage to bile ducts |
| Surgical resection | Direct physical excision of tumour with clear tissue margins | Localised tumours with clear anatomical margins and good organ reserve | Invasive; not feasible when tumours encase critical vascular structures |
As explained in our guide to radiofrequency ablation, heat-based treatments are well established for small, isolated nodules in solid parenchymal organs. However, when treating tumours encasing the portal vein in the pancreas or abutting delicate nerves in the prostate, the non-thermal action of irreversible electroporation offers distinct anatomical advantages.
Who is a suitable candidate for NanoKnife ablation?
Suitability for NanoKnife is determined through a formal multidisciplinary tumour board review. Favourable candidates generally include patients with locally advanced, non-metastatic pancreatic cancer that has demonstrated stability after induction chemotherapy; men with localized, intermediate-risk prostate cancer desiring focal organ-sparing ablation; and individuals with primary liver tumours or isolated liver metastases situated adjacent to major vascular bifurcations where surgery or thermal ablation is contraindicated.
Conversely, patients are not candidates if they have widespread distant metastases, uncontrolled systemic infections, or severe uncorrected bleeding disorders. Absolute contraindications include cardiac pacemakers, implantable cardioverter-defibrillators (ICDs), or severe cardiac arrhythmias, because electrical pulses can disrupt electronic devices or trigger ventricular dysrhythmias. Furthermore, metallic clips, stents, or surgical implants positioned directly inside the planned electrical field preclude treatment, as metal distorts the current distribution and can cause unpredictable thermal heating.
NanoKnife before and after: what do imaging scans and results show?
Because irreversible electroporation is an oncological procedure rather than cosmetic surgery, NanoKnife before and after outcomes are measured strictly through radiological imaging and biological markers rather than photographs. Before the procedure, multiphase contrast CT, dynamic contrast-enhanced MRI, or PSMA PET scans define the baseline tumour margins, vascular encasement, and cellular activity.
In the immediate days following treatment, local tissue swelling is expected. Follow-up diagnostic imaging is routinely scheduled at one, three, and six months post-procedure. A successful ablation demonstrates an absence of contrast uptake within the treated zone, confirming that active tumour vascularity has been eliminated. Over subsequent months, scavenger macrophages gradually remove apoptotic cellular material, leading to progressive shrinkage of the treated lesion. In prostate cases, successful ablation correlates with substantial drops in PSA levels and clear follow-up biopsies; in pancreatic cases, sustained local control without vascular occlusion represents a successful clinical outcome.
Your trip to Turkey and NanoKnife recovery milestones
When planning treatment with NanoKnife, Turkey offers specialised facilities where an international medical trip typically lasts seven to ten days. Following arrival and initial hospital consultations, comprehensive pre-operative testing and imaging reviews take place on the first day. The procedure is performed on day two, followed by one to three nights of inpatient monitoring in a private hospital room.
During the initial 24 to 48 hours of NanoKnife recovery, patients may experience mild soreness, fatigue, or transient nausea, which are managed with routine prescription medications. Hospital teams encourage gentle walking within 24 hours to stimulate venous circulation. Temporary urinary catheters or surgical drains are typically removed within three to five days. A post-operative clinical review and imaging check are conducted before discharge, after which patients are cleared to fly home. Most individuals can return to light desk work within seven to fourteen days, while strenuous exercise should be deferred for three to four weeks.
Risks, side effects and safety considerations of NanoKnife therapy
Every interventional procedure carries potential risks that must be carefully reviewed. The primary intra-operative consideration during irreversible electroporation is the potential for cardiac arrhythmias, which is controlled through continuous ECG synchronisation that restricts electrical discharges to the heart's absolute refractory period. General surgical risks include puncture-site bruising, localized haematoma, infection, and reactions to anaesthesia.
Organ-specific risks depend on the treatment site. In pancreatic ablation, potential complications include transient pancreatitis, temporary pancreatic or bile duct leaks, and localized fluid collections. For liver ablation, risks involve temporary elevation of hepatic enzymes or rare portal vein thrombosis. For prostate ablation, transient dysuria, haematuria, or mild urinary retention may occur, although the risk of permanent urinary incontinence or erectile dysfunction is substantially lower than with radical surgical prostatectomy. Guidelines from bodies such as the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) and NICE emphasise that treatment should be undertaken only in experienced tertiary centres with immediate intensive care capabilities.
How to choose an oncology centre in Turkey and key red flags
When selecting a hospital for irreversible electroporation, ensure the facility holds national ministry licensing and reputable international accreditations such as JCI. Verify that the clinical team consists of certified interventional radiologists and surgical oncologists who possess verified training and extensive case experience in irreversible electroporation. The centre must feature advanced hybrid operating suites with integrated CT guidance, dedicated cardiac-gating monitors, and 24-hour on-site intensive care facilities.
Be alert to critical red flags: never proceed with a clinic that guarantees a complete cancer cure, claims the procedure is free of complications, offers NanoKnife for widely metastatic cancer, or issues an unitemised quote without a detailed review of recent CT or MRI discs by a multidisciplinary tumour board. You can read more about how it works when coordinating treatment abroad, and request a specialist review through our free quote enquiry form.
Questions to ask your multidisciplinary oncology team
Preparing specific questions helps you make an informed decision alongside your medical team:
- Has my diagnostic imaging been reviewed by a full multidisciplinary tumour board including interventional and medical oncologists?
- Why is irreversible electroporation recommended for my tumour instead of surgical resection, stereotactic radiotherapy, or thermal ablation?
- How many NanoKnife procedures has your interventional team performed in my specific target organ?
- How many single-use electrode needle probes will be needed for my ablation, and are all consumable charges included in the written price?
- What exact protocols are used for cardiac synchronisation and post-procedure intensive care monitoring?
- What follow-up imaging schedule and biological marker checks will be required once I travel back to my home country?
Taking time to discuss these questions allows you to explore comprehensive oncology treatments in Turkey or request an initial free quote with clarity regarding your individual clinical path.
Hospitals with Oncology in Turkey
Frequently asked questions
NanoKnife is a medical system that performs irreversible electroporation, a focal ablation technique using targeted high-voltage electrical pulses. The electrical currents generate nanoscale perforations in cancer cell membranes, causing cell death through natural apoptosis. Because it does not rely on extreme heat or freezing, it preserves nearby collagen-rich structures such as blood vessels, ducts, and nerve bundles.
Clinical evidence demonstrates that irreversible electroporation is effective for local tumour ablation in carefully selected cases, particularly where lesions border vital blood vessels that preclude surgical excision or thermal ablation. It provides local disease control for tumours in the pancreas, prostate, and liver. However, it is not a systemic cure for metastatic disease and is typically part of a comprehensive oncology strategy.
NanoKnife in Turkey typically ranges from approximately €11,000 to €22,000, compared with €18,000 to €35,000 in the UK. The total price depends on the target organ, the number of single-use electrode probes required, operating theatre time, and inpatient hospital care. Hospitals provide an exact price following a multidisciplinary review of recent diagnostic imaging.
Unlike aesthetic surgery where changes are visible on the skin, NanoKnife results are evaluated through radiological imaging. Baseline scans show the vascular tumour, while follow-up MRI or contrast-enhanced CT scans at one, three, and six months typically demonstrate a non-enhancing ablation zone, absence of active tumour blood supply, gradual tissue shrinkage, and stable or declining tumour blood markers.
Radiofrequency ablation uses intense heat to destroy tissue, which carries a risk of thermal damage to nearby bile ducts, bowel walls, or nerves, and suffers from cooling near large blood vessels. In contrast, NanoKnife delivers non-thermal electrical pulses, enabling safe ablation directly adjacent to major arteries and veins without damaging the structural extracellular matrix.
The treatment is performed under general anaesthesia with complete muscle relaxation, meaning you feel nothing during the procedure. Post-operative discomfort is usually moderate and managed with prescription analgesics. Patients treated for prostate tumours may experience temporary urinary irritation, while abdominal treatments can cause transient localized ache or nausea that settles over several days.
Most patients stay in hospital for one to three nights for monitoring. Light everyday activities can usually be resumed within seven to ten days, while return to full work and physical exercise typically takes two to four weeks. Full internal tissue healing and resolution of local swelling continue over two to three months under scheduled radiological follow-up.
NanoKnife is evaluated by bodies like the NHS and FDA as an effective option for selected indications, but it carries clinical risks. These include temporary cardiac arrhythmias during electrical pulse delivery, local haematoma, bleeding, temporary bile leaks or pancreatitis in pancreatic cases, and transient urinary symptoms in prostate ablation. Experienced teams use real-time cardiac synchronisation to minimise cardiac risks.
NanoKnife provides targeted local tumour control rather than a guaranteed cure. In prostate cancer, it can ablate the primary lesion while preserving continence and potency. In locally advanced pancreatic cancer, it aims to clear margins around encased vessels and slow progression. Recurrence remains possible if microscopic malignant cells exist outside the treatment zone, making ongoing oncological surveillance vital.
Patients generally spend seven to ten days in Turkey. This duration allows for pre-procedure blood testing and imaging verification, the ablation procedure with one to three nights of inpatient hospital recovery, and a post-operative review by the interventional team. Once surgical drains or catheters are removed and your clinical status is cleared, you are safe to travel home.
Patient stories